Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
Public ClinicalTrials.gov record NCT05152524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.
Study identification
- NCT ID
- NCT05152524
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 25, 2022 (Actual)
- Primary completion
- Dec 30, 2025 (Actual)
- Completion
- Mar 30, 2026 (Actual)
- Last update posted
- Aug 12, 2026
2022 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lakewood Regional Medical Center | Los Angeles | California | 90013 | — |
| Los Robles | Thousand Oaks | California | 91360 | — |
| WellStar Research Institute | Marietta | Georgia | 30060 | — |
| Advocate Aurora Research Institute, | Chicago | Illinois | 60657 | — |
| Corewell Health (Spectrum) | Grand Rapids | Michigan | 49085 | — |
| Munson Medical Center | Traverse City | Michigan | 49684 | — |
| University of Buffalo | Buffalo | New York | 14203 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Mount Sinai | New York | New York | 10029 | — |
| Stony Brook University | Stony Brook | New York | 11794 | — |
| Mercy Health | Toledo | Ohio | 43604 | — |
| Semmes Murphey Foundation | Memphis | Tennessee | 38120 | — |
| Valley Baptist Medical Center | Harlingen | Texas | 78550 | — |
| Texas Stroke Institute | Plano | Texas | 75075 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05152524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05152524 live on ClinicalTrials.gov.